Genetic Testing - Global Strategic Business Report

The global market for Genetic Testing was valued at US$15.0 Billion in 2024 and is projected to reach US$26.4 Billion by 2030, growing at a CAGR of 9.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Genetic Testing market.

Global Genetic Testing Market - Key Trends & Drivers Summarized

What Is Genetic Testing and How Does It Impact Healthcare?

Genetic testing involves analyzing DNA sequences to identify changes in genes, chromosomes, or proteins that could indicate the presence of or risk for developing genetic disorders. This type of testing has revolutionized the medical field by enabling early diagnosis and personalized treatment plans for a wide array of diseases, including cancers, cardiovascular diseases, and rare genetic disorders. By identifying specific genetic mutations, healthcare providers can tailor treatments to individual patients, enhancing treatment efficacy and potentially reducing side effects. Genetic testing also plays a pivotal role in prenatal screening, carrier screening, and in predicting an individual’s risk of developing certain diseases.

What Technological Advancements Are Shaping Genetic Testing?

The field of genetic testing has been profoundly impacted by advancements in genomic technologies, particularly next-generation sequencing (NGS) and CRISPR. NGS allows for the rapid sequencing of entire genomes at a fraction of the cost and time previously required. This technology has not only expanded the accessibility of genetic testing but also improved the accuracy and reliability of the results. Meanwhile, CRISPR technology, known for its gene-editing capabilities, is being explored for its potential to correct genetic defects before they can lead to disease. Additionally, improvements in bioinformatics and the integration of artificial intelligence have enhanced the ability to analyze and interpret large sets of genetic data, providing more detailed and actionable insights.

How Are Regulatory and Ethical Considerations Influencing the Genetic Testing Market?

The genetic testing market is heavily influenced by regulatory and ethical considerations. As genetic testing becomes more commonplace, issues such as privacy, consent, and access to genetic information have prompted governments worldwide to establish strict guidelines and regulations. These regulations aim to protect individuals from genetic discrimination and ensure that genetic data is handled with confidentiality and integrity. Furthermore, ethical concerns regarding how genetic testing is used - for example, in prenatal screening or for determining the likelihood of developing late-onset diseases - continue to shape public policy and influence consumer acceptance and trust in genetic testing services.

What Drives the Growth in the Genetic Testing Market?

The growth in the genetic testing market is driven by several factors, including the increasing prevalence of genetic disorders, technological advancements in genetics, and a growing awareness of the benefits of early disease detection and prevention. The expansion of direct-to-consumer genetic testing kits has also significantly contributed to market growth, as more individuals take proactive steps towards understanding their genetic health. Additionally, healthcare systems are increasingly adopting personalized medicine practices, which rely heavily on genetic insights to craft individualized treatment plans. Moreover, ongoing research and development activities, supported by funding from governments and private entities, are continually uncovering new applications for genetic testing, further broadening the market's scope.

Report Scope

The report analyzes the Genetic Testing market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Type (Prenatal & Newborn, Diagnostic, Predictive & Presymptomatic, Carrier, Pharmacogenomic, Other Types); Application (Cancer, Genetic Disease, Cardiovascular Disease, Other Applications).

Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Cancer segment, which is expected to reach US$13.6 Billion by 2030 with a CAGR of a 9.7%. The Genetic Disease segment is also set to grow at 10.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $6.0 Billion in 2024, and China, forecasted to grow at an impressive 11.9% CAGR to reach $1.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Genetic Testing Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Genetic Testing Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Genetic Testing Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Agilent Technologies, Inc., Asuragen, Inc., Biocartis NV, Agena Bioscience, Inc., ARUP Laboratories and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 249 companies featured in this Genetic Testing market report include:

• Agilent Technologies, Inc.
• Asuragen, Inc.
• Biocartis NV
• Agena Bioscience, Inc.
• ARUP Laboratories
• Bioiberica SAU
• AutoGenomics, Inc.
• Biodesix, Inc.
• Admera Health
• Annoroad Gene Technology
• Berry Genomics Co., Ltd.
• Ariel Precision Medicine, Inc.
• AlphaBiolabs Ltd.
• AnchorDx
• Alexian Brothers of America, Inc.

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry